Mechanism of action
Covalent irreversible binding to BTK cysteine 481 prevents B-cell receptor signaling, inhibiting autoreactive B-cell activation and autoantibody production in pemphigus.
Next-generation oral BTK inhibitor for autoimmune blistering diseases. Rapid onset with favorable safety profile vs 1st generation BTK inhibitors.
© 2025[current_year] The Doctors Platform. All Right Reserved.
© 2026 The Doctors Platform. All Right Reserved.